Altimmune (ALT) Cash from Restructuring (2015 - 2017)

Altimmune (ALT) reported Cash from Restructuring of -$66633.0 for Q1 2017, up 66.13% year-over-year from -$40109.6 in Q1 2016, and little changed quarter-over-quarter from -$66633.0 in Q4 2016.

Altimmune (ALT) Cash from Restructuring (2015 - 2017) Analysis & Trends

Altimmune (ALT) has 3 years of Cash from Restructuring data on file, last reported at -$66633.0 in Q1 2017.

  • Cash from Restructuring for Q1 2017 came in at -$66633.0, up 66.13% year-over-year; the trailing twelve-month figure through Mar 2017 was -$267300.0 (up 83.35% YoY), and the FY2016 annual result was -$397383.0, down 182.49% from the prior year.
  • Cash from Restructuring held at -$66633.0 in Q1 2017 per ALT's latest filing, from -$66633.0 in the prior quarter.
  • Over five years, Cash from Restructuring peaked at $1.9 million in Q1 2015 and troughed at -$1.1 million in Q2 2015.
  • A 3-year average of $7306.6 and a median of -$66727.0 in 2016 frame the typical range for Cash from Restructuring.
  • On a YoY basis, Cash from Restructuring climbed as much as 93.93% in 2016 and fell as far as 762.99% in 2016.
  • A 3-year view of Cash from Restructuring shows it stood at -$319008.0 in 2015, then surged by 79.11% to -$66633.0 in 2016, then changed by 0.0% to -$66633.0 in 2017.
  • Business Quant data shows ALT's Cash from Restructuring at -$66633.0 in Q1 2017, -$66633.0 in Q4 2016, and -$67307.0 in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Altimmune 336.67 Mn 336.67 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2017 -66,633.00
Dec 31, 2016 -66,633.00
Sep 30, 2016 -67,307.00
Jun 30, 2016 -66,727.00
Mar 31, 2016 -196,716.00
Dec 31, 2015 -319,008.00
Sep 30, 2015 10,152.00
Jun 30, 2015 -1.10 Mn
Mar 31, 2015 1.94 Mn